Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients

Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation

(2015) Juan F. Delgado et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Prevention and treatment of coronary artery vasculopathy

(2012) Maria G. Crespo-Leiro et al.   Current Opinion in Organ Transplantation

The Registry of the International Society for Heart and Lung Transplantation: 29th Official Adult Heart Transplant Report—2012

(2012) Josef Stehlik et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Cumulative Incidence of Cytomegalovirus Infection and Disease After Heart Transplantation in the Last Decade: Effect of Preemptive Therapy

(2012) E. Mendez-Eirin et al.   TRANSPLANTATION PROCEEDINGS

Endothelial Dysfunction and Cardiac Allograft Vasculopathy

(2012) Monica Colvin-Adams et al.   Journal of Cardiovascular Translational Research

Factors associated with the development of cardiac allograft vasculopathy - a systematic review of observational studies

(2011) J. R. Braga et al.   CLINICAL TRANSPLANTATION

Cytomegalovirus: recent progress in understanding pathogenesis and control

(2011) V. C. Emery   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

Does Cytomegalovirus Serology Impact Outcome After Pediatric Heart Transplantation?

(2009) William T. Mahle et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Prophylaxis Versus Preemptive Anti-cytomegalovirus Approach for Prevention of Allograft Vasculopathy in Heart Transplant Recipients

(2009) Luciano Potena et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Acute Cellular Rejection and the Subsequent Development of Allograft Vasculopathy After Cardiac Transplantation

(2009) Eugenia Raichlin et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION